68 results
DEFA14A
FULC
Fulcrum Therapeutics Inc
19 Apr 24
Additional proxy soliciting materials
4:08pm
Additional Materials
Soliciting Material Pursuant to §240. 14a-12
FULCRUM THERAPEUTICS, INC.
(Name of Registrant as Specified in Its Charter)
(Name … previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
Fulcrum
8-K
io1g270peat61e3w4k
22 Aug 23
Regulation FD Disclosure
7:01am
8-K
ubgaiwav5kv
10 Jul 23
Entry into a Material Definitive Agreement
5:06pm
DEFA14A
44582fnrj6
28 Apr 23
Additional proxy soliciting materials
4:10pm
PRE 14A
a9cfqixy v6
18 Apr 23
Preliminary proxy
4:05pm
8-K
EX-1.1
l4vfd0b4d1aphd3iugxq
16 Aug 22
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
5:59pm
424B5
7ubp9vyugmb9g
16 Aug 22
Prospectus supplement for primary offering
5:55pm
424B5
fth1t1
15 Aug 22
Prospectus supplement for primary offering
6:14pm